Colette Frawley (61), who has suffered excruciating and debilitating migraines since childhood, recently discovered cannabidiol (CBD) oil, a derivative of cannabis. It has, she says, changed her life. Having been on “every painkiller in the book” since 10, she is now off all painkillers. Instead she takes instead three drops of CBD oil three times […]

by

American Chemistry Society(Photo: Metro) Researchers have invented a range of instruments from giant telescopes to rovers to search for life in outer space, but so far, these efforts have yielded no definitive evidence that it exists beyond Earth. Now scientists have developed a new tool that can look for signs of life with 10,000 times […]

by

TUESDAY, Dec. 6, 2016 — A purified oral version of a marijuana compound may help with treatment-resistant forms of epilepsy, two new clinical trials show. The researchers found that the compound, cannabidiol (CBD), helped reduce seizure frequency in children and adults with two hard-to-treat forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. The drug is […]

by

The Minnesota Department of Health is considering adding autism to the growing list of conditions in which the patients can be prescribed medical cannabis. Posted:Oct 02 2016 11:14PM CDT Updated:Oct 03 2016 04:32PM CDT Children with autism could soon be prescribed medical marijuana n n Health Autistic children could… read more at: http://www.fox9.com/health/209275506-story

by

 Dive Brief:  A study by AXIM Biotechnologies, a global leader in cannabinoid research and maker of CanChew Plus CBD Gum, found that 30 mg doses of cannabidiol (CBD) helped alleviate irritable bowel syndrome (IBS) symptoms in patients, according to a news release. “These results show that excellent bioavailability for CBD may be achieved via our […]

by

Upon closing of the Transaction, one director designee of Talent shall be appointed to the board of directors of Kalytera. The vendors of Talent have each agreed to a 12-month lock-up in respect to any Kalytera shares issued on closing and as future contingent payments. Closing of the Transaction is subject to certain conditions customary […]

by

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jan. 13, 2017) – Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (“Kalytera”) is pleased to announce that it has entered into a binding letter of intent (the “LOI”) to acquire all of the issued and outstanding securities of Talent Biotechs Ltd. (“Talent”), a privately held, Israeli-based developer of proprietary cannabidiol (“CBD”) therapeutics (the […]

by

 Dive Brief:  A study by AXIM Biotechnologies, a global leader in cannabinoid research and maker of CanChew Plus CBD Gum, found that 30 mg doses of cannabidiol (CBD) helped alleviate irritable bowel syndrome (IBS) symptoms in patients, according to a news release. “These results show that excellent bioavailability for CBD may be achieved via our […]

by

 Dive Brief:  A study by AXIM Biotechnologies, a global leader in cannabinoid research and maker of CanChew Plus CBD Gum, found that 30 mg doses of cannabidiol (CBD) helped alleviate irritable bowel syndrome (IBS) symptoms in patients, according to a news release. “These results show that excellent bioavailability for CBD may be achieved via our […]

by